Process for making CGRP receptor antagonists
View Patent ↗The disclosure encompasses a novel process for making piperidinone carboxamide indane and azainane derivatives, having less steps and improved yields as compared to previous synthetic methods for making these compounds, which are CGRP receptor antagonists, useful for the treatment of migraine. Conditions for an amide bond formation between an acid and amine include for example reacting the compounds of Formulae B (after salt break) and C with an amide coupling reagent and optionally an additive and an acid and/or a base in a non-reactive solvent.
1. A process for making a compound of Formula I
or a pharmaceutically acceptable salt thereof, wherein:
X is —C(R 3 )═ or N—, wherein R 3 is hydrogen, F or CN;
Y is CH or N;
R 1 is: C 1-4 alkyl, cyclopropylmethyl, cyclobutylmethyl, or [1-(trifluoromethyl)cyclopropyl]methyl, each of which may optionally be substituted with one or more substituents as allowed by valence, which are independently: F or hydroxy; and
R 2 is 0 to 5 substituents which are independently for each occurrence: methyl, F, Cl, or Br;
said process comprising crystallizing the compound of Formula A
in the presence of an arylaldehyde derivative and a first acid in a first organic solvent to yield the compound of Formula B
optionally as a salt, and coupling the compound of Formula B with a compound of Formula C
or a salt thereof, under conditions for an amide bond formation between an acid and an amine to yield a compound of Formula I.
2. The process according to claim 1 where the compound of Formula B is coupled with a compound of Formula C after salt break by reacting the reagents with an amide coupling reagent in a non-reactive solvent to yield a compound of Formula I.
3. The process according to claim 2 wherein the amide coupling regant is selected from the group consisting of EDC, HATU, T3P® and CDI, and the non-reactive solvent is an organic/aqueous mixture selected from the group consisting of DCM/water, iPAC/water, acetonitrile/water, acetone/water, iPA/water and THF/water.
4. The process according to claim 2 futher comprising an amide coupling reagent additive selected from the group consisting of HOBT and HOPO.
5. The process according to claim 1 wherein a salt of a compound of Formula C is coupled to the compound of Formula B.
6. The process according to claim 1 wherein the arylaldehyde derivative is selected from 2-hydroxybenzaldehyde, 2-hydroxy-5-nitrobenzaldehyde and 2-hydroxy-3,5-dichlorobenzaldehyde.
7. The process according to claim 1 further comprising making the compound of Formula A by reacting a compound of Formula D
wherein Z is an amine protecting group, with an electrophilic alkylating agent that delivers a cationic R 1 , in the presence of a base, optionally an additive in a second organic solvent and optionally salt additive to yield a compound of Formula E
and
deprotecting the compound of Formula E to yield a compound of Formula A.
8. The process according to claim 7 wherein the electrophilic alkylating agent is R 1 —OS(O) 2 CF 3 or R 1 —OS(O) 2 F, or R 1 —OS(O) 2 R F , wherein R F is a polyfluorinated one to six membered carbon chain.
9. The process according to claim 8 wherein: Z is t-butyl-O—C(O)—, deprotection is effected by reacting the compound of Formula D with a second acid, the base is a lithium base, the additive is an aprotic polar solvent, and the second organic solvent is selected from the group consisting of THF, Me-THF and MTBE.
10. The process according to claim 9 wherein the lithium base is selected from the group consisting of LiOBut and LiOPent t .
11. The process according to claim 9 wherein the second acid selected from the group consisting of HCl, MeSO 3 H, H 2 SO 4 , p-toluenesulfonic acid and benzenesulfonic acid.